PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. hameln pharma ltd
HP

hameln pharma ltd

Gloucester
SME

Hameln Pharma Ltd is an internationally operating pharmaceutical group specializing in the development, licensing, and marketing of high-quality generic injectable medicines. Their products are used in various medical settings, including hospitals and outpatient surgery centers.

hameln.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£67.5m
Live
43
Buyers
11
12m
£58.7m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts43 / 54
  • Top buyers11
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — hameln pharma ltdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

hameln pharma ltd has won £67.5m across 11 public-sector buyers, with 43 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 91% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
43 of 54Live contracts
91%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
EnvironmentNo commitment stated✓
Tackling inequalityNo commitment stated✓
Community1 commitment ↗✓
Community · 1
  • WebsiteCorporate Social ResponsibilityHameln Pharma is committed to corporate social responsibility, focusing on the wellbeing of patients and healthcare professionals.

Extracted automatically from hameln.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 3
Generic Injectable MedicinesHigh quality generic injectable medicines used in hospitals, pharmacies, and palliative care. ↗Intelligent Packaging DesignInnovative packaging solutions for injectable medicines to enhance safety and usability. ↗Robust Supply ChainA reliable supply chain ensuring the availability of medicines. ↗
Frameworks & DPS · 2 from notices
  • Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (T&T) · £1.7m
  • Contract for the supply of dexamethasoneDepartment of Health and Social Care (T&T) · £148k

Extracted automatically from hameln.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 43 live · 11 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£37.2m16 mopending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£21.6m1.7 yrspending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
Supportive Medicines - Alfentanil 25mg/50ml vial - Direct Award
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency3360000014 Feb 2022£12 moClosed
Potassium iodate/iodide 2021-22
Secretary of State for Health and Social Care acting as part of the Crown through Public Health England3360000001 Jul 2021£19 moClosed
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)
Department of Health and Social Care (T&T)3360000001 Dec 2020£1.0m—Closed
Supportive Medicines including ITU, EOL & Antibiotics
Department of Health and Social Care (T&T)3360000017 Sept 2020£1.7m11 moClosed
Supportive Medicines including ITU, EOL & Antibiotics
Department of Health and Social Care (T&T)3360000017 Sept 2020£1.7m11 moClosed
Total live value £376k · mean award £1.3m1–10 of 54

Top buyers · 11 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
14 contracts
91%
since 2022
2
Department of Health and Social Care (T&T)
8 contracts
9%
since 2020
3
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
4 contracts
0%
since 2022
4
Secretary of State for Health and Social Care acting as part of the Crown through Public Health England
2 contracts
0%
since 2021
5
Procurement and Logistics Service, Business Services Organisation
2 contracts
0%
6
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
13 contracts
0%
7
Regional Business Services Organisation Procurement and Logistics Service
1 contract
0%
8
University Hospitals of Derby and Burton NHS Foundation Trust
1 contract
0%
9
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
5 contracts
0%
10
Procurement and Logistics Service
3 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire14 contracts
100%
London6 contracts
0%
Northern Ireland6 contracts
0%
Scotland13 contracts
0%
East Midlands1 contract
0%
Wales5 contracts
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). hameln pharma ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
HP
hameln pharma ltd
Yes£58.7m—
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Due in -44d
Next due 27 May 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
01034697
Status
Active
Type
Private limited
Incorporated
14 Dec 1971
Reg. office
Nexus Hurricane Road, Gloucester Business Park, Gloucester, Gloucestershire, GL3 4AG
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • WATKIN, Stephen Allen — director
    Appointed 28 Sept 2022
  • KUETER, Beate — director
    Appointed 01 Apr 2022
  • Mr Christoph Kerstein — person with significant control
    ownership of shares 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
HAMELN PHARMA LTD
01034697 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.